Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

ENDRA Life Sciences (NDRA) Operating Income (2016 - 2025)

ENDRA Life Sciences has reported Operating Income over the past 6 years, most recently at -$3.1 million for Q4 2021.

  • Quarterly Operating Income fell 36.25% to -$3.1 million in Q4 2021 from the year-ago period, while the trailing twelve-month figure was -$11.5 million through Dec 2021, changed 0.03% year-over-year, with the annual reading at -$5.8 million for FY2025, 46.72% up from the prior year.
  • Operating Income was -$3.1 million for Q4 2021 at ENDRA Life Sciences, down from -$2.7 million in the prior quarter.
  • Over five years, Operating Income peaked at -$360697.0 in Q1 2017 and troughed at -$3.3 million in Q3 2020.
  • The 5-year median for Operating Income is -$2.6 million (2019), against an average of -$2.4 million.
  • Year-over-year, Operating Income tumbled 686.7% in 2018 and then grew 27.99% in 2020.
  • A 5-year view of Operating Income shows it stood at -$2.3 million in 2017, then increased by 12.79% to -$2.0 million in 2018, then crashed by 56.31% to -$3.1 million in 2019, then grew by 27.99% to -$2.3 million in 2020, then tumbled by 36.25% to -$3.1 million in 2021.
  • Per Business Quant, the three most recent readings for NDRA's Operating Income are -$3.1 million (Q4 2021), -$2.7 million (Q3 2021), and -$3.2 million (Q2 2021).